common.study.topics.clinical
Imaging Study of Metastatic Prostate Cancer
common.study.values.description
“Hyperpolarized Carbon-13 Imaging of Metastatic Prostate Cancer”
A pilot study with a group of up to 10 men with CRPC about to embark on a 6-month course of treatment with radium 223. Study participants will undergo anatomical MR imaging combined with the new hyperpolarized MRI (1 hour exam) prior to treatment.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-yes
Hyperpolarized Pyruvate (13C)
MRI contrast agent
participant.views.study.view.additional
participant.views.study.view.scientific-title
Hyperpolarized Carbon-13 Imaging of Metastatic Prostate Cancer
common.study.values.clinical-trial-id
NCT02844647
participant.views.study.view.id
lejBye
